New hope for babies: drug and vaccine combo may block hepatitis b at birth
NCT ID NCT05705427
First seen Feb 25, 2026 · Last updated May 16, 2026 · Updated 10 times
Summary
This study tested whether giving pregnant women with hepatitis B a daily pill (tenofovir) plus a vaccine at birth can safely prevent passing the virus to their babies. Over 300 mothers in the Democratic Republic of Congo took part, and researchers tracked safety and how well the approach worked. The goal is to find a simple, effective way to protect newborns in areas with limited healthcare.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Université Protestant au Congo
Kinshasa, Democratic Republic of the Congo
Conditions
Explore the condition pages connected to this study.